Cas:239085-97-3 N-(2,2-Diethoxyethyl)-4-fluoroaniline manufacturer & supplier

Chemical Name:N-(2,2-Diethoxyethyl)-4-fluoroaniline

CAS.NO:239085-97-3

Synonyms:N-(2,2-Diethoxyethyl)-4-fluoroaniline

Molecular Formula:C₁₂H₁₈FNO₂

Molecular Weight:227.27500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:323.6ºC at 760mmHg

Density:1.088g/cm3

Index of Refraction:1.51

PSA:30.49000

Exact Mass:227.13200

LogP:2.70970

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-(2,2-Diethoxyethyl)-4-fluoroaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(2,2-Diethoxyethyl)-4-fluoroaniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(2,2-Diethoxyethyl)-4-fluoroaniline Use and application,N-(2,2-Diethoxyethyl)-4-fluoroaniline technical grade,usp/ep/jp grade.

Related News: Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets. N-(2,2-Diethoxyethyl)-4-fluoroaniline manufacturer Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost. N-(2,2-Diethoxyethyl)-4-fluoroaniline supplier GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection. N-(2,2-Diethoxyethyl)-4-fluoroaniline vendor At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase. N-(2,2-Diethoxyethyl)-4-fluoroaniline factory Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.